Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer.

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.